Brief: 1nkemia reports new corporate deals with Pharmamel, Mind the Byte and Barcelona Bioscience

1nkemia IUCT SA

14/10/2015 12:19

Oct 14 (Reuters) - 1nkemia IUCT Group SA  IKM.MC : 
    * Says the fund managed by the group's unit IUCT Empren 
enters into share capital of Pharmamel SL 
    * Says the investment of 75,000 euros ($85,470) was for 980 
shares (6.6 percent) of Pharmamel and IUCT Empren has the right 
to buy additional 980 shares for the same amount in the next 
three years  
    * Says to take part in the share capital increase of Mind 
the Byte SL (MtB) via its unit IUCT Empren 
    * InKemia to cover 10 percent of the share capital increase 
of 100,000 euros and IUCT Empren to reach 5.5 percent in MtB 
    * Says its unit IUCT SA signs cooperation agreement to be 
main technology supplier of Barcelona Bioscience SL 
 
Source text: http://bit.ly/1jo4eQd 
     
Further company coverage:  IKM.MC  
 
($1 = 0.8775 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))